Journal of Pharmacovigilance

Editor Note for Journal of Pharmacovigilance

Patricia Vergara Aragon^* National Autonomous University of Mexico, Mexico
^*Correspondence: Patricia Vergara Aragon, National Autonomous University of Mexico, Mexico, Email:

Received: 10-Jul-2020 Published: 31-Jul-2020, DOI: 10.35248/2329-6887.20.8.279

Dear Readers,

We are very much delighted to mention all of you that we have completed our 8th successful year in the arena of publishing and research on Pharmacovigilance. Over the past 8 years we have spread our wings across the globe and have collaborated with many scholars, researchers and budding scientific community who has contributed to our growth and success. Our combined continuous efforts has received a tremendous response and attracted billions of readers across the globe. Journal of Pharmacovigilance expresses sincere gratitude to all its elite panel of editorial board members for their continuous efforts, valuable support and encouragement throughout the publication journey of the journal, and the journal publish quality of research and becoming as one of the leading and well-recognized broadcaster of scientific outcomes in the field of studies related to findings developments from public health, global health policy planning and implementation research. The objective of JP is to publish high-quality and original research papers alongside relevant and insightful reviews. As such, the journal aspires to be vibrant, engaging and accessible, and at the same time integrative and challenging, Needless to say, any papers that you wish to submit, either individually or collaboratively, are much appreciated and will make a substantial contribution to the early development and success of the journal. The objective of Journal of Pharmacovigilance is to publish high-quality original research papers, survey reports, case studies, narratives, review article, short communication, clinical data, epidemiologic studies, thesis and relevant and insightful reviews. Every year we published with different volumes and different issues. Each issue of the journal covered with different types of topics in the field of publishing and freely disseminate drug safety and toxicity findings. All published papers, are subject to the journal’s double-blind review process. The topics for the 2019 year were varied and exciting. The biggest category was probably drug Safety, but there is so much more involving scientists as academies and young researchers. The current volume of the journal is 8 with issue 3. The Timeline of processing from Submission to Publication is 45 days. Manuscripts will be published within 7 days of acceptance. The social media can play a key role in spreading the research work increased visibility, citation and ultimately the impact of published works. We promote published articles to the social media. On behalf of the Longdom Publishing JP Editorial Board and the whole Editorial Office, I would like to express our gratefulness to the authors of articles published during the past years, and to acknowledge generous help which both the authors and editors obtained from the peerreviewers. Our aspiration is to facilitate scientific discovery in new ways by exploring new technologies in the field of Journal of Pharmacovigilance.

Regards,

Editorial team

Journal of Pharmacovigilance

Whatsapp: +32-466-901905

E-mail: drugsafety@journalsoa.org